Form 4: HealthStream EVP Coady Reports Routine Stock Transactions
Insider Transaction Report
HealthStream Executive Vice President Trisha L. Coady reported the acquisition of shares from RSU vesting and subsequent sale for tax obligations.
Summary
- Executive Vice President Trisha L. Coady reported transactions involving HealthStream Inc. common stock on September 29, 2025.
- Coady acquired 869 shares of common stock through the vesting of restricted share units (RSUs).
- Concurrently, 212 shares were disposed of at a price of $29.08 per share to cover tax liabilities associated with the RSU vesting.
- Following these transactions, Coady beneficially owns 30,589 shares of common stock directly.
- Two tranches of Restricted Share Units (RSUs) partially matured, with 562 units and 307 units converting to common stock, respectively, on the transaction date.
- After these conversions, 1,828 and 1,741 unvested RSUs remain outstanding from these grants.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive. While there's a sale of shares, it's for tax purposes related to the vesting of equity awards, which is a positive event for the executive. The overall transaction is routine and reflects ongoing executive compensation and alignment.
Positives
- The vesting of Restricted Share Units (RSUs) indicates continued service and aligns executive compensation with company performance.
- The acquisition of 869 shares increases the executive's direct equity stake in HealthStream Inc. (HSTM).
Negatives
- The disposal of 212 shares, while for tax purposes, reduces the executive's direct beneficial ownership of common stock.
Future Outlook
The reporting person has significant unvested Restricted Share Units (RSUs) remaining, with scheduled vesting events extending through September 2028, contingent upon continued service. These future vestings represent potential additional common stock acquisitions for the executive, reinforcing long-term alignment with shareholder interests.
Industry Context
Insider transactions, particularly those related to RSU vesting and tax withholding, are routine occurrences for executives in publicly traded companies across all industries. This filing reflects standard executive compensation practices and does not indicate any specific industry-wide trends or competitive shifts.
Stakeholder Impact
- Shareholders: The transaction is a routine insider filing and does not indicate any material change in company fundamentals or strategy. It reflects ongoing executive compensation practices.
- Employees: No direct impact on employees is indicated by this filing.
- Management: The executive continues to accumulate equity through vesting, aligning their interests with long-term company performance.
Next Steps
- Remaining 1,828 RSUs from one grant are scheduled to vest as follows: 20% on September 20, 2025; 30% on September 20, 2026; and 35% on September 20, 2027.
- Remaining 1,741 RSUs from another grant are scheduled to vest as follows: 15% on September 18, 2025; 20% on September 18, 2026; 30% on September 18, 2027; and 35% on September 18, 2028.
Key Dates
| Date | Description |
|---|---|
| 09/20/2024 | 15% of a Restricted Share Unit (RSU) grant vested. |
| 09/18/2025 | 15% of a Restricted Share Unit (RSU) grant is scheduled to vest. |
| 09/20/2025 | 20% of a Restricted Share Unit (RSU) grant is scheduled to vest. |
| 09/29/2025 | Reporting date for acquisition of 869 shares from RSU vesting and disposal of 212 shares for tax liability. |
| 09/18/2026 | 20% of a Restricted Share Unit (RSU) grant is scheduled to vest. |
| 09/20/2026 | 30% of a Restricted Share Unit (RSU) grant is scheduled to vest. |
| 09/18/2027 | 30% of a Restricted Share Unit (RSU) grant is scheduled to vest. |
| 09/20/2027 | 35% of a Restricted Share Unit (RSU) grant is scheduled to vest. |
| 09/18/2028 | 35% of a Restricted Share Unit (RSU) grant is scheduled to vest. |
Recommendation
holdThis Form 4 filing details routine insider transactions related to executive compensation (RSU vesting and tax withholding). It does not provide new fundamental information about HealthStream Inc.'s operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. Investors should 'hold' their position based on this filing, as it confirms standard executive equity management rather than signaling a shift in company prospects.
Keywords
HSTM, HealthStream, Form 4, Insider Transaction, Restricted Share Units, Executive Compensation, Stock Vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.